Nimed (Nimesulide)

Nimesulide, the active ingredient in Nimed, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It is indicated for mild to moderate pain, inflammatory conditions such as osteoarthritis, and fever in adult patients.

GNH USA supplies Nimed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory‑approved batches.

Nimesulide acts on inflammatory pathways to relieve pain and reduce fever. It is commonly prescribed for the following conditions: - Mild to moderate pain: provides analgesic relief by decreasing inflammation and pain perception. - Osteoarthritis: alleviates joint discomfort and improves mobility through inhibition of prostaglandin synthesis. - Fever: lowers elevated body temperature by acting on hypothalamic thermoregulatory centers.

Nimesulide may cause a range of adverse reactions. The most frequently reported events are generally mild and reversible.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or mild pruritus. - Elevated liver enzymes without clinical symptoms.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury, potentially fatal. - Severe cutaneous reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Renal impairment: acute kidney injury, especially in dehydrated patients. - Anaphylactic reactions: sudden onset of swelling, bronchospasm, or hypotension. - Blood dyscrasias: agranulocytosis or thrombocytopenia.

Before prescribing Nimesulide, clinicians should consider several safety measures. - Assess liver function before initiating: baseline tests recommended. - Avoid in patients with known hypersensitivity to NSAIDs: discontinue if reaction occurs. - Use caution in elderly: increased risk of gastrointestinal bleeding and renal dysfunction. - Do not combine with other COX‑2 inhibitors or high‑dose aspirin: risk of additive toxicity. - Pregnancy and lactation: contraindicated unless benefits outweigh risks. - Store at room temperature: keep in the original packaging, protect from moisture and light.

Nimesulide can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin, heparin): increased risk of bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal and renal toxicity. - Cyclosporine or tacrolimus: heightened nephrotoxicity. - Methotrexate: increased methotrexate plasma concentrations and toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: may reduce renal function, especially in volume‑depleted patients. - SSRIs or SNRIs: potential for increased bleeding risk. - Lithium: possible rise in lithium serum levels. - ACE inhibitors or ARBs: may impair renal function when combined.